Article Information
History
- September 23, 2023.
Article Versions
- You are currently viewing Version 1 of this article (September 23, 2023 - 20:30).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Konstantin Senkevich, MD, PhD1,2,
- Lang Liu, MSc1,2,3,
- Chelsea X. Alvarado4,5,
- Hampton L. Leonard, MSc4,5,6,
- Mike A. Nalls, PhD4,5 and
- Ziv Gan-Or, MD, PhD1,2,3,*
- 1The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada
- 2Department of Neurology and neurosurgery, McGill University, Montréal, QC, Canada, Canada
- 3Department of Human Genetics, McGill University, Montréal, QC, Canada
- 4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA, 20814
- 5Data Tecnica, Washington, DC, USA, 200373
- 6DZNE Tübingen, Tübingen, Germany
- ↵*Correspondence to: Ziv Gan-Or McGill University, 1033 Pine Avenue, West, Ludmer Pavilion, room 312 Montreal, QC, H3A 1A1, Phone: +1-514-398-5845, Fax. +1-514 398-8248, Email: ziv.gan-or{at}mcgill.ca
Posted September 23, 2023.
Genetics of NLRP3 suggests lack of involvement and inefficient druggability in Parkinson’s disease
